ELIZABETH GRAY: Open Payments
NPI 1366925158 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 111 payments from 19 companies in 2025. Trend: 2023 $1,437 · 2024 $1,985 · 2025 $2,451
Food & beverage: $2,451
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $363 |
| PFIZER INC. | 17 | $344 |
| Janssen Biotech, Inc. | 10 | $284 |
| ABBVIE INC. | 11 | $217 |
| Aimmune Therapeutics, Inc. | 6 | $155 |
| Phathom Pharmaceuticals, Inc. | 7 | $153 |
| Madrigal Pharmaceuticals | 5 | $151 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $121 |
| GENZYME CORPORATION | 6 | $106 |
Products named: XIFAXAN, TREMFYA, DUPIXENT, VELSIPITY, ZENPEP, VOQUEZNA, REZDIFFRA, XELJANZ.
Industry payments across NC — which companies pay providers there.
